6108 — New Ray Medicine International Holding Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapValue Trap

Market Cap
HK$60.19m
Enterprise Value
-HK$43.48m
Revenue
HK$50.15m

Annual balance sheet for New Ray Medicine International Holding, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	88.7	65.8	150	154	104
Net Total Accounts Receivable
Net Total Receivables	41.5	17	64.4	54	240
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	301	349	484	404	378
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34.7	34.2	31.4	34.4	29.4
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	679	650	662	540	492
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13.4	33.1	19.5	7.85	5.55
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	24.4	44.2	29.5	14.2	11.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	654	606	633	526	480
Total Liabilities & Shareholders' Equity	679	650	662	540	492
Total Common Shares Outstanding